Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Novel Drug Delivery Systems in Cancer Therapy Revenue 1.4 Market Analysis by Type 1.4.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Nanoparticles 1.4.3 Liquid Embolics 1.4.4 Embolization Particles 1.5 Market by Application 1.5.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Application: 2020 VS 2026 1.5.2 Hospitals & Clinic 1.5.3 Cancer Treatment Centers 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Novel Drug Delivery Systems in Cancer Therapy Market Perspective (2015-2026) 2.2 Novel Drug Delivery Systems in Cancer Therapy Growth Trends by Regions 2.2.1 Novel Drug Delivery Systems in Cancer Therapy Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Novel Drug Delivery Systems in Cancer Therapy Historic Market Share by Regions (2015-2020) 2.2.3 Novel Drug Delivery Systems in Cancer Therapy Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Novel Drug Delivery Systems in Cancer Therapy Market Growth Strategy 2.3.6 Primary Interviews with Key Novel Drug Delivery Systems in Cancer Therapy Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Novel Drug Delivery Systems in Cancer Therapy Players by Market Size 3.1.1 Global Top Novel Drug Delivery Systems in Cancer Therapy Players by Revenue (2015-2020) 3.1.2 Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Players (2015-2020) 3.1.3 Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Novel Drug Delivery Systems in Cancer Therapy Market Concentration Ratio 3.2.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Novel Drug Delivery Systems in Cancer Therapy Revenue in 2019 3.3 Novel Drug Delivery Systems in Cancer Therapy Key Players Head office and Area Served 3.4 Key Players Novel Drug Delivery Systems in Cancer Therapy Product Solution and Service 3.5 Date of Enter into Novel Drug Delivery Systems in Cancer Therapy Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Novel Drug Delivery Systems in Cancer Therapy Historic Market Size by Type (2015-2020) 4.2 Global Novel Drug Delivery Systems in Cancer Therapy Forecasted Market Size by Type (2021-2026) 5 Novel Drug Delivery Systems in Cancer Therapy Breakdown Data by Application (2015-2026) 5.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) 5.2 Global Novel Drug Delivery Systems in Cancer Therapy Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Novel Drug Delivery Systems in Cancer Therapy Market Size (2015-2020) 6.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in North America (2019-2020) 6.3 North America Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) 6.4 North America Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) 7 Europe 7.1 Europe Novel Drug Delivery Systems in Cancer Therapy Market Size (2015-2020) 7.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in Europe (2019-2020) 7.3 Europe Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) 7.4 Europe Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) 8 China 8.1 China Novel Drug Delivery Systems in Cancer Therapy Market Size (2015-2020) 8.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in China (2019-2020) 8.3 China Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) 8.4 China Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) 9 Japan 9.1 Japan Novel Drug Delivery Systems in Cancer Therapy Market Size (2015-2020) 9.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in Japan (2019-2020) 9.3 Japan Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) 9.4 Japan Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Size (2015-2020) 10.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) 10.4 Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) 11 India 11.1 India Novel Drug Delivery Systems in Cancer Therapy Market Size (2015-2020) 11.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in India (2019-2020) 11.3 India Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) 11.4 India Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Size (2015-2020) 12.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in Central & South America (2019-2020) 12.3 Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) 12.4 Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Teva 13.1.1 Teva Company Details 13.1.2 Teva Business Overview and Its Total Revenue 13.1.3 Teva Novel Drug Delivery Systems in Cancer Therapy Introduction 13.1.4 Teva Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)) 13.1.5 Teva Recent Development 13.2 Johnson & Johnson 13.2.1 Johnson & Johnson Company Details 13.2.2 Johnson & Johnson Business Overview and Its Total Revenue 13.2.3 Johnson & Johnson Novel Drug Delivery Systems in Cancer Therapy Introduction 13.2.4 Johnson & Johnson Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) 13.2.5 Johnson & Johnson Recent Development 13.3 Roche 13.3.1 Roche Company Details 13.3.2 Roche Business Overview and Its Total Revenue 13.3.3 Roche Novel Drug Delivery Systems in Cancer Therapy Introduction 13.3.4 Roche Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) 13.3.5 Roche Recent Development 13.4 Takeda 13.4.1 Takeda Company Details 13.4.2 Takeda Business Overview and Its Total Revenue 13.4.3 Takeda Novel Drug Delivery Systems in Cancer Therapy Introduction 13.4.4 Takeda Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) 13.4.5 Takeda Recent Development 13.5 AbbVie 13.5.1 AbbVie Company Details 13.5.2 AbbVie Business Overview and Its Total Revenue 13.5.3 AbbVie Novel Drug Delivery Systems in Cancer Therapy Introduction 13.5.4 AbbVie Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) 13.5.5 AbbVie Recent Development 13.6 Samyang Biopharmaceuticals 13.6.1 Samyang Biopharmaceuticals Company Details 13.6.2 Samyang Biopharmaceuticals Business Overview and Its Total Revenue 13.6.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems in Cancer Therapy Introduction 13.6.4 Samyang Biopharmaceuticals Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) 13.6.5 Samyang Biopharmaceuticals Recent Development 13.7 Celgene 13.7.1 Celgene Company Details 13.7.2 Celgene Business Overview and Its Total Revenue 13.7.3 Celgene Novel Drug Delivery Systems in Cancer Therapy Introduction 13.7.4 Celgene Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) 13.7.5 Celgene Recent Development 13.8 Spectrum Pharmaceuticals, Inc. 13.8.1 Spectrum Pharmaceuticals, Inc. Company Details 13.8.2 Spectrum Pharmaceuticals, Inc. Business Overview and Its Total Revenue 13.8.3 Spectrum Pharmaceuticals, Inc. Novel Drug Delivery Systems in Cancer Therapy Introduction 13.8.4 Spectrum Pharmaceuticals, Inc. Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) 13.8.5 Spectrum Pharmaceuticals, Inc. Recent Development 13.9 Gilead Sciences 13.9.1 Gilead Sciences Company Details 13.9.2 Gilead Sciences Business Overview and Its Total Revenue 13.9.3 Gilead Sciences Novel Drug Delivery Systems in Cancer Therapy Introduction 13.9.4 Gilead Sciences Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) 13.9.5 Gilead Sciences Recent Development 13.10 Shire (Baxalta) 13.10.1 Shire (Baxalta) Company Details 13.10.2 Shire (Baxalta) Business Overview and Its Total Revenue 13.10.3 Shire (Baxalta) Novel Drug Delivery Systems in Cancer Therapy Introduction 13.10.4 Shire (Baxalta) Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) 13.10.5 Shire (Baxalta) Recent Development 13.11 Merrimack 10.11.1 Merrimack Company Details 10.11.2 Merrimack Business Overview and Its Total Revenue 10.11.3 Merrimack Novel Drug Delivery Systems in Cancer Therapy Introduction 10.11.4 Merrimack Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) 10.11.5 Merrimack Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Novel Drug Delivery Systems in Cancer Therapy Key Market Segments Table 2. Key Players Covered: Ranking by Novel Drug Delivery Systems in Cancer Therapy Revenue Table 3. Ranking of Global Top Novel Drug Delivery Systems in Cancer Therapy Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Novel Drug Delivery Systems in Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Nanoparticles Table 6. Key Players of Liquid Embolics Table 7. Key Players of Embolization Particles Table 8. Global Novel Drug Delivery Systems in Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Regions (2015-2020) Table 12. Global Novel Drug Delivery Systems in Cancer Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Novel Drug Delivery Systems in Cancer Therapy Market Growth Strategy Table 18. Main Points Interviewed from Key Novel Drug Delivery Systems in Cancer Therapy Players Table 19. Global Novel Drug Delivery Systems in Cancer Therapy Revenue by Players (2015-2020) (Million US$) Table 20. Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Players (2015-2020) Table 21. Global Top Novel Drug Delivery Systems in Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Novel Drug Delivery Systems in Cancer Therapy as of 2019) Table 22. Global Novel Drug Delivery Systems in Cancer Therapy by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Novel Drug Delivery Systems in Cancer Therapy Product Solution and Service Table 25. Date of Enter into Novel Drug Delivery Systems in Cancer Therapy Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) (Million US$) Table 28. Global Novel Drug Delivery Systems in Cancer Therapy Market Size Share by Type (2015-2020) Table 29. Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Type (2021-2026) Table 30. Global Novel Drug Delivery Systems in Cancer Therapy Market Size Share by Application (2015-2020) Table 31. Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) (Million US$) Table 32. Global Novel Drug Delivery Systems in Cancer Therapy Market Size Share by Application (2021-2026) Table 33. North America Key Players Novel Drug Delivery Systems in Cancer Therapy Revenue (2019-2020) (Million US$) Table 34. North America Key Players Novel Drug Delivery Systems in Cancer Therapy Market Share (2019-2020) Table 35. North America Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) (Million US$) Table 36. North America Novel Drug Delivery Systems in Cancer Therapy Market Share by Type (2015-2020) Table 37. North America Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) (Million US$) Table 38. North America Novel Drug Delivery Systems in Cancer Therapy Market Share by Application (2015-2020) Table 39. Europe Key Players Novel Drug Delivery Systems in Cancer Therapy Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Novel Drug Delivery Systems in Cancer Therapy Market Share (2019-2020) Table 41. Europe Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) (Million US$) Table 42. Europe Novel Drug Delivery Systems in Cancer Therapy Market Share by Type (2015-2020) Table 43. Europe Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) (Million US$) Table 44. Europe Novel Drug Delivery Systems in Cancer Therapy Market Share by Application (2015-2020) Table 45. China Key Players Novel Drug Delivery Systems in Cancer Therapy Revenue (2019-2020) (Million US$) Table 46. China Key Players Novel Drug Delivery Systems in Cancer Therapy Market Share (2019-2020) Table 47. China Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) (Million US$) Table 48. China Novel Drug Delivery Systems in Cancer Therapy Market Share by Type (2015-2020) Table 49. China Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) (Million US$) Table 50. China Novel Drug Delivery Systems in Cancer Therapy Market Share by Application (2015-2020) Table 51. Japan Key Players Novel Drug Delivery Systems in Cancer Therapy Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Novel Drug Delivery Systems in Cancer Therapy Market Share (2019-2020) Table 53. Japan Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) (Million US$) Table 54. Japan Novel Drug Delivery Systems in Cancer Therapy Market Share by Type (2015-2020) Table 55. Japan Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) (Million US$) Table 56. Japan Novel Drug Delivery Systems in Cancer Therapy Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Novel Drug Delivery Systems in Cancer Therapy Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Novel Drug Delivery Systems in Cancer Therapy Market Share (2019-2020) Table 59. Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Share by Type (2015-2020) Table 61. Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Share by Application (2015-2020) Table 63. India Key Players Novel Drug Delivery Systems in Cancer Therapy Revenue (2019-2020) (Million US$) Table 64. India Key Players Novel Drug Delivery Systems in Cancer Therapy Market Share (2019-2020) Table 65. India Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) (Million US$) Table 66. India Novel Drug Delivery Systems in Cancer Therapy Market Share by Type (2015-2020) Table 67. India Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) (Million US$) Table 68. India Novel Drug Delivery Systems in Cancer Therapy Market Share by Application (2015-2020) Table 69. Central & South America Key Players Novel Drug Delivery Systems in Cancer Therapy Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Novel Drug Delivery Systems in Cancer Therapy Market Share (2019-2020) Table 71. Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Share by Type (2015-2020) Table 73. Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Share by Application (2015-2020) Table 75. Teva Company Details Table 76. Teva Business Overview Table 77. Teva Product Table 78. Teva Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$) Table 79. Teva Recent Development Table 80. Johnson & Johnson Company Details Table 81. Johnson & Johnson Business Overview Table 82. Johnson & Johnson Product Table 83. Johnson & Johnson Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$) Table 84. Johnson & Johnson Recent Development Table 85. Roche Company Details Table 86. Roche Business Overview Table 87. Roche Product Table 88. Roche Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$) Table 89. Roche Recent Development Table 90. Takeda Company Details Table 91. Takeda Business Overview Table 92. Takeda Product Table 93. Takeda Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$) Table 94. Takeda Recent Development Table 95. AbbVie Company Details Table 96. AbbVie Business Overview Table 97. AbbVie Product Table 98. AbbVie Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$) Table 99. AbbVie Recent Development Table 100. Samyang Biopharmaceuticals Company Details Table 101. Samyang Biopharmaceuticals Business Overview Table 102. Samyang Biopharmaceuticals Product Table 103. Samyang Biopharmaceuticals Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$) Table 104. Samyang Biopharmaceuticals Recent Development Table 105. Celgene Company Details Table 106. Celgene Business Overview Table 107. Celgene Product Table 108. Celgene Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$) Table 109. Celgene Recent Development Table 110. Spectrum Pharmaceuticals, Inc. Business Overview Table 111. Spectrum Pharmaceuticals, Inc. Product Table 112. Spectrum Pharmaceuticals, Inc. Company Details Table 113. Spectrum Pharmaceuticals, Inc. Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$) Table 114. Spectrum Pharmaceuticals, Inc. Recent Development Table 115. Gilead Sciences Company Details Table 116. Gilead Sciences Business Overview Table 117. Gilead Sciences Product Table 118. Gilead Sciences Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$) Table 119. Gilead Sciences Recent Development Table 120. Shire (Baxalta) Company Details Table 121. Shire (Baxalta) Business Overview Table 122. Shire (Baxalta) Product Table 123. Shire (Baxalta) Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$) Table 124. Shire (Baxalta) Recent Development Table 125. Merrimack Company Details Table 126. Merrimack Business Overview Table 127. Merrimack Product Table 128. Merrimack Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$) Table 129. Merrimack Recent Development Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Type: 2020 VS 2026 Figure 2. Nanoparticles Features Figure 3. Liquid Embolics Features Figure 4. Embolization Particles Features Figure 5. Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Application: 2020 VS 2026 Figure 6. Hospitals & Clinic Case Studies Figure 7. Cancer Treatment Centers Case Studies Figure 8. Others Case Studies Figure 9. Novel Drug Delivery Systems in Cancer Therapy Report Years Considered Figure 10. Global Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Regions: 2020 VS 2026 Figure 12. Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Players in 2019 Figure 15. Global Top Novel Drug Delivery Systems in Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Novel Drug Delivery Systems in Cancer Therapy as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Novel Drug Delivery Systems in Cancer Therapy Revenue in 2019 Figure 17. North America Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Teva Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Teva Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) Figure 26. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Johnson & Johnson Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) Figure 28. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Roche Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) Figure 30. Takeda Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Takeda Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) Figure 32. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. AbbVie Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) Figure 34. Samyang Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Samyang Biopharmaceuticals Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) Figure 36. Celgene Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Celgene Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) Figure 38. Spectrum Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Spectrum Pharmaceuticals, Inc. Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) Figure 40. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Gilead Sciences Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) Figure 42. Shire (Baxalta) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Shire (Baxalta) Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) Figure 44. Merrimack Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Merrimack Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) Figure 46. Bottom-up and Top-down Approaches for This Report Figure 47. Data Triangulation Figure 48. Key Executives Interviewed

Teva Johnson & Johnson Roche Takeda AbbVie Samyang Biopharmaceuticals Celgene Spectrum Pharmaceuticals, Inc. Gilead Sciences Shire (Baxalta) Merrimack